JMP Securities initiated coverage on Kalvista Pharmaceuticals Inc (NASDAQ: KALV), assigning a Market Outperform rating and setting a price target of $19.00. Currently trading at $8.77, the stock has ...

Astria Therapeutics' focus on leveraging its half-life extension technology to create long-acting mAbs targeting derisked targets in established markets has positioned the company favorably in the ...

JMP Securities analyst Jonathan Wolleben initiated coverage of Astria Therapeutics (ATXS) with an Outperform rating and $26 price target ...

JMP Securities initiated coverage of KalVista (KALV) with an Outperform rating and $19 price target KalVista is developing sebetralstat, a ...

Alexandria Real Estate Equities (NYSE:ARE – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by equities researchers at JMP Securities in a report released on Wednesday,Benzinga ...

Blend Labs Inc (BLND) stock saw a modest uptick, ending the day at $3.92 which represents a slight increase of $0.09 or 2.35% from the prior close of $3.83. The stock opened at $3.82 and touched a low ...

AI is evolving rapidly with recent breakthroughs making it more accessible and efficient than ever. Smaller, cost-effective ...

The web services and cybersecurity specialist's share price ended the day's trading up 10.7% amid the backdrop of a 0.8% gain ...

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

This article focuses on the latest stock ratings and analyst calls on AI companies involved in digital advertising, drone ...

These investments include Treasury bills, Treasury notes, Treasury bonds, Floating Rate Notes (FRNs), and Treasury Inflation-Protected Securities (TIPS). Individuals with brokerage accounts can ...

JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...